top of page

Year:
2015
Vertical:
Health & Nutrition
Ranking:
Top 3
Inositec
Inositec AG is developing first-in-class treatments for soft tissue calcification disorders based on its proprietary Inositune™ platform of inositol phosphate (IP6) analogs. The company’s lead programs address vascular and renal calcification disorders, including orphan indications.

bottom of page